Metabolic research
Tirzepatide
Dual GIP and GLP-1 receptor agonist research compound supplied as a lyophilised powder.
Supplier documentation available on request. Independent reports are published where held — see current lab reports.
No reconstitution supplies needed. Bought separately for a standard vial, water, needles and wipes come to £14.
Are you sure you have these? Select them. A standard vial arrives as lyophilised powder. Bacteriostatic water, insulin needles and alcohol wipes are needed to prepare it in the laboratory. Nothing is added unless you tick it.
Add £30 more for free UK delivery · free from £100
Also available as: Tirzepatide Pen Vial (pre-filled kit)
Overview
Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual receptor agonist, with activity reported in the literature at the GIP and GLP-1 receptors. It is among the most studied incretin-class compounds in metabolic-research literature and is supplied as a lyophilised powder for laboratory use.
In a research setting it is examined in vitro and in preclinical models for its dual-receptor binding and signalling profile and as an analytical reference standard. It is provided strictly as a research reference material and is not a medicine, not for human or animal consumption.
Research areas
- Co-agonist binding and signalling at the GIP and GLP-1 receptors, studied in vitro
- Comparative pharmacology against GLP-1-only reference peptides
- Peptide stability, solubility and handling in laboratory preparations
- Use as an analytical reference standard
At a glance
- supplier-stated purity
- UK stocked, 24–48h dispatch after payment
- Stored frozen until dispatch
- Supplier documentation on request
Storage and handling
Supplied as a lyophilised powder in a sealed vial and kept frozen until dispatch. Unopened vials are typically stored at -20°C for the long term and 2-8°C for short periods. After reconstitution with bacteriostatic water, vials are generally refrigerated at 2-8°C, protected from light, and not subjected to repeated freeze-thaw cycles.
Specification
| Compound type | GIP / GLP-1 dual receptor agonist |
|---|---|
| Structure | 39-amino-acid peptide (C-terminal amide) |
| Molecular formula | C225H348N48O68 |
| Molecular weight | ~4814 g/mol |
| CAS number | 2023788-19-2 |
| Synonyms | LY3298176 |
| Purity | Supplier stated |
| Form | Lyophilised powder |
| Storage | -20°C long-term; 2-8°C short-term |
Questions
What is Tirzepatide supplied as?
A lyophilised powder in a sealed vial with supplier-stated purity, stored frozen until dispatch. Supplier documentation is available on request where held.
What receptors does Tirzepatide act on?
It is described in the literature as a dual receptor agonist with reported activity at the GIP and GLP-1 receptors. It is supplied only as a reference material for research.
What purity is your Tirzepatide?
Each listing reflects supplier-stated purity. Supplier documentation available on request where held.
Is Tirzepatide for research use only?
Yes. It is supplied strictly for laboratory research and is not for human or animal consumption.
